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A number of mainly observational studies suggest that many African females below the age of one year die each year from the
nonspeciﬁc eﬀects of vaccination with diphtheria-tetanus toxoids and killed (whole-cell) Bordetella pertussis (DTwP). In contrast,
similarstudies suggest that manyAfrican femalesandmales mayhavetheir lives savedeach year by thenonspeciﬁc immunological
beneﬁts of Bacillus Calmette-Guerin (BCG) vaccination. From an immunological point of view, we hypothesise that the adverse
eﬀects of DTwP vaccine may occur because of the Th2-polarising eﬀect of the aluminium phosphate adjuvant in the vaccine and
because intramuscular administration of the vaccine may cause chronic inﬂammation at the site of injection. However, the Th1-
polarising eﬀect of BCG is likely to be beneﬁcial. Sexual dimorphism aﬀecting immune functions and vitamin A supplementation
may inﬂuence both the deleterious and beneﬁcial nonspeciﬁc eﬀects of immunisation.
1.Background
The paper discusses the immunology behind the reported
nonspeciﬁc eﬀects of DTwP and BCG vaccination: increased
childhood mortality rates after DTwP and decreased mortal-
ity rates after BCG vaccination given during the course of
the WHO recommended vaccine programs implemented in
Guinea-Bissau and other low-income countries [1, 2]. Both
the detrimental and the beneﬁcial eﬀects of vaccination are
strongest in females [3–7]. We speculate here that vaccine-
induced changes in innate and adaptive immunity may play
a role.
2.DTwPVaccine
According to the WHO recommendations children in low-
income countries are vaccinated against diphtheria, tetanus,
and pertussis at 6, 10, and 14 weeks of age. Most countries
use a whole-cell Bordetella pertussis vaccine. A typical DTwP
vaccine dose (0.5mL) from the Serum Institute of India
contains diphtheria toxoid (25Lf), tetanus toxoid (5Lf), and
pertussis toxoid (4IU), aluminium phosphate (1.5mg), and
a preservative, thiomersal (0.01%). Aluminium phosphate
acts primarily as an antigen-adsorbing and Th2-polarizing
adjuvant [8]. Intramuscular vaccine injection results in a
palpable sore induration at the site of injection in 70% of
children. In 9% of the children the induration lasts 4 weeks
and there is a signiﬁcant correlation between local reactivity
and fever (J. Agergaard, personal communication).
3.Increased MortalityafterDTwPVaccination
The major causes of death in general among children in
Guinea-Bissau are related to gastrointestinal infections with
diarrhoea and dehydration, pneumonia and septicaemia,
whereas the risk of death from pertussis, even in unim-
munized high-mortality areas, is relatively low [2]. Up to
recently, malaria has also been a major cause of death in
Guinea-Bissau (C. Stabell Benn, personal communication).
A number of observational studies in Guinea-Bissau
have shown that DTwP vaccination is associated with an
increased mortality in female infants [3–5, 9] most probably
reﬂecting higher rates of fatal diarrhoea and pneumonia2 Journal of Tropical Medicine
among vaccinated children. In line with this, observational
studies on the morbidity of vaccinated versus nonvaccinated
children have shown that DTwP vaccination is associated
with increased incidence of colonisation and infections
with endemically occurring rotavirus [10]a n dCryptosporid-
ium parvum [11] in females. Both microorganisms cause
extensive diarrhoea, dehydration, and death. Furthermore,
recentlypublished randomised trials found increased risks of
growth retardation, Chlamydia pneumoniae infections, and
morbidity (diarrhoea) in girls who had received a DTwP
booster vaccine [12, 13]. It should be noted that Chlamydia
infection per se is unlikely to cause the high proportions of
fatal pneumonia in infant females after DTwP vaccination as
observed by Veirum et al. [9].
4.Immunology
Are there immunological mechanisms to explain the delete-
riousnonspeciﬁceﬀectsofintramuscularDTwPvaccination?
F i r s ti ts h o u l db es t r e s s e dt h a tt h eD T w Pv a c c i n ei nu s ep r o -
vides eﬃcient protection against the three diseases targeted
by the vaccine. However, the intramuscular injection, which
leads to a Th2-dominated protective antibody response [8],
mightbe theproblemper se. Thus, theintramuscular vaccine
deposit, which slowly releases the aluminium-adsorbed
vaccine antigens, causes long-lasting local induration at the
siteofvaccinationinsomechildren.Theindurationprobably
reﬂects a local inﬂammatory reaction with accumulation
of phagocytic and lymphoid cells including bone marrow-
derived macrophages. These cells are triggered and activated
by vaccine antigens to secrete inﬂammatory and fever-
inducing cytokines like TNFα,I L - 6 ,a n dI L 1 β [14]. Elevated
circulating levels of these cytokines may be highly correlated
with mortality in infants with severe endemic infections
(see above) [15]. Ongoing inﬂammation might also lead to
macrophage reprogramming toward a type 2 macrophage
proﬁle secreting immunosuppressive cytokines such as IL-
10 and TGFβ [15]. Such reprogramming would, in concert
with the Th2-polarizing eﬀect of aluminium phosphate [8],
dampen protective cellular immunity in general. Enhanced
systemic levels of IL-10 and TGFβ together with insuﬃcient
cellular immunity may lead to an increased susceptibility to
the endemic pathogens mentioned above.
Heterogenous cell populations of myeloid-derived sup-
pressor cells (MDSCs) are primarily known for their im-
munosuppressive and tumor-promoting eﬀects within and
outside a tumor environment [16]. However, MDSC-like
cells may also be recruited and respond to stress and dan-
ger signals including DTwP vaccine-induced inﬂammation
(overview in [17]), and they may accumulate in and dis-
seminate from the inﬂammatory site of the DTwP injection.
Like type 2 macrophages, MDSC-like cells secrete immu-
nosuppressive cytokines such as TGFβ and IL-10 which
are involved in recruitment of regulatory T cells (Treg).
Treg activity may decrease levels of protective immunity
thereby increasing the risk of morbidity and mortality due
to endemic pathogens [10, 11, 18, 19]. In addition, pertussis
toxin (PT), present in DTwP, changes levels of Th1/Th2
cytokines [20] and might decrease resistance to infectious
pathogens. Thus, animals primed with puriﬁed and detox-
iﬁed PT or DTwP followed by exposure to respiratory
syncytial virus showed an increased morbidity (weight loss)
and mortality compared with micenot primedwith PT prior
to virus challenge [21].
5.Nonspeciﬁc Decreased Mortalityafter
BCG Vaccination
Protection by one invading microorganism, for example,
by vaccination, against another unrelated microorganism is
recognized as heterologous immunity (HI) [22]. HI also
implicates that the pool of speciﬁc immunological memory
of an individual will be changed for each new infection or
vaccine experienced by the individual.
BCG vaccination may lead to HI since it appears to
have some positive survival eﬀects not related to its speciﬁc
protection against tuberculosis. Thus, the reduced overall
mortality from BCG vaccinations, not related to TB, has
been estimated to be 25% [1]. Likewise, BCG vaccination
in children less than two years old in low-income countries
appears to provide signiﬁcant protection against infectious
diseases with a deadlyoutcome[6,7]. This beneﬁtappears to
be strongest for females [6, 7]. In a randomised trial among
low-birth-weight children who do not normally receive BCG
at birth, BCG administered at birth was associated with a
45% (11–65%) survival beneﬁt in the ﬁrst month of life
(P. Aaby et al. submitted for publication).
6.Immunology
BCG vaccination in young infants nonspeciﬁcally increases
polio-speciﬁc antibody responses after polio vaccination
but not after diphtheria or tetanus vaccination [23]. This
nonspeciﬁc, immune-enhancing eﬀect of BCG is probably
due to stimulation of innate immunity, that is, enhanced
antigen presenting activity and eﬃcacy. The mycobacterial
cell wall activates and diﬀerentiates dendritic cells and
macrophages through TLR2, -4, and -9 ligation increasing
their functional activity [23–26] and polarizing towards
Th1-type immune responses with increased levels of IFNγ,
TNFα, and other inﬂammatory cytokines. This may in turn
enhance immune responses towards infections other than
tuberculosis. In addition, the TLR2 and -4 agonist activities
of BCG lead to activation of inducible nitric oxide synthase
(iNOS) in macrophages triggering their capacity to kill
intracellular microorganisms. These changes may lead to the
more general protection against endemic infectious diseases
and thereby explain the decreased mortality rates among
BCG-vaccinated children.
7.Cutaneousversus Intramuscular
Administrationand AluminiumAdjuvant
Subcutaneous and intradermally injected vaccines against
BCG, measles, and smallpox are taken up and processedJournal of Tropical Medicine 3
locally bymacrophages and dendriticcellsat the site ofinjec-
tion. The cells reach the regional lymph nodes via aﬀerent
lymphatics and thus the physiologically correct microen-
vironment for priming of T and B cells. Heterologous
immunityaftervaccine-inducedactivationofregionallymph
nodes might well lead to an increased overall “immune
awareness” at the systemic level. A “natural” nonspeciﬁc
eﬀect of cutaneous vaccinations with live microorganisms
might explain the overall positive eﬀect on the mortality
rate not only following BCG vaccination but also following
vaccinations against smallpox [27, 28]a n dm e a s l e s[ 29, 30].
On the contrary, intramuscular injection of DTwP
aluminium adsorbed antigens might stick to the site of
injection and here recruit inﬂammatory cells including
antigen-processing cells. Antigen-loaded cells will leave the
inﬂammatory sitebythelymphaswellasbytherichcapillary
bed of skeletal muscles and via this latter route reach the
spleen, an organ in which robust antibody responses speciﬁc
for the vaccine antigens are generated. The Th2-polarizing
eﬀect of aluminium phosphate together with recruitment
of myeloid-derived suppressor cells might at the same time
lower the overall eﬃcacy of protective cellular immunity
necessary for elimination of intracellular, potentially lethal
infectious microorganisms in the environment, as discussed
above.
8.SexDifferencesinNonspeciﬁc
Vaccine Effects
As mentioned above, the mortality after vaccination is
markedly diﬀerent in females and males: DTwP vaccina-
tion increases overall female but not male mortality [3–
5], whereas the heterologous eﬀects of BCG and measles
vaccines reduce females mortality with less signiﬁcant eﬀects
in males [6, 7, 29, 30]. Immune dimorphism, that is, the
diﬀerences in immune responses and regulation between
sexes, is primarily thought to be caused by the immune
modulatory eﬀects of the sex hormones [31, 32]. In young
male and female infants the diﬀerent levels of sex hormones
may result in both quantitative and qualitative diﬀerences
in immunity between the two sexes. In 0-to-2-year old
females, levels of plasma estradiol are comparable to levels
of the late puberty or adult mid-follicular phase [33, 34],
whilst in 0–6-month-old males, the plasma testosterone
levels approach those of adults [34]. In particular, estradiol
levelsare high in prematuregirls[34].TheTh1/Th2 cytokine
balance is greatly inﬂuenced by sex hormones. Th1 cells
secrete proinﬂammatory cytokines like IFNγ and TNFα,
whereas Th2 cells secrete anti-inﬂammatory cytokines like
IL-4, IL-5, IL-10, and IL-13. Importantly, the two Th subsets
are mutually inhibitory. Physiological levels of estradiol
stimulate in particular humoral immune responses, whereas
testosterone inhibits such responses [31, 32, 35]. The
eﬀects of estradiol on the generation of Th2-derived anti-
inﬂammatory cytokines in infant females might therefore
inhibit secretion of Th1-derived inﬂammatory cytokines
and skew the immune response towards Th2-type responses
including Treg stimulation (for overview, see [36]a n d[ 37]).
Upon DTwP vaccination of baby females, as compared to
males, the adjuvant-containing vaccine per se (as discussed
above) alongside the estradiol-rich environment may lead to
a more strongly polarized Th2 immunity at the expense of
nonspeciﬁc and protective Th1-type immunity. In contrast,
BCG vaccination, which by itself enhances the Th1 arm,
as discussed above, might outweigh the negative eﬀects of
estradiol on Th1-type responses in female infants but leave
their Th2-type responses intact. Thus, the BCG vaccinated
females will gain an overall broader general immune protec-
tionthanthemaleswho lackthestrong Th2-polarizing eﬀect
of estradiol.
9.VitaminA Supplementation
In spite of numerous studies, there is still only weak evidence
for any eﬀect of micronutrient supplementation on vaccine
eﬃcacy (reviewed in [38]). However, recent studies strongly
suggest that supplementation with vitamin A, iron, and
zinc enhances both the detrimental nonspeciﬁc eﬀects of
DTwP vaccination in infant girls and the beneﬁcial eﬀects
of BCG vaccination [39, 40]. Vitamin A supplementation
has been shown to enhance the speciﬁc antibody responses
in infants vaccinated against diphtheria [41]a n dt e t a n u s
[42]. Hypothetically, this speciﬁc antibody-enhancing eﬀect
of vitamin A might outcompete protective responses to
endemic pathogens (see above), thus explaining the harmful
eﬀect of vitamin A supplementation in DTwP vaccines.
Vitamin A supplementation might also increase the activity
of regulatory T cells [43] and thereby potentially down-
modulate protective adaptive responses against endemic
pathogens. Vitamin A supplementation has also been shown
to increase NK-cell activity in immunosuppressed infants
[44], which together with the nonspeciﬁc stimulatory eﬀect
of BCG on the innate immune system [24–26]m i g h t
improve the beneﬁcial survival eﬀect observed after BCG
vaccination.
10.ConclusionsandSuggestions
The deleterious eﬀect of DTwP vaccination in infant females
andthebeneﬁcialoutcomesofBCGvaccinationmightreﬂect
nonspeciﬁc immune-polarizing and nonintended regulatory
eﬀects of vaccines and sex hormones in early childhood. The
datafromWestAfricaonthenonspeciﬁceﬀectsofDTwPand
BCG vaccination in young children discussed here suggest
(1) replacement of intramuscular DTwP vaccination with
cutaneous vaccination or development of a DTwP vaccine
live bacterial carrier such as BCG [45] which may reduce
nonspeciﬁc negative eﬀects,(2)that BCGvaccination should
be performed within the ﬁrst week after birth to maximally
improve its nonspeciﬁc eﬀect on overall survival, (3) that
many new vaccines against tuberculosis under development
should be tested not only for their overall eﬀects on tuber-
culosis but also for their overall eﬀect on infant mortality,
(4) that research into sex diﬀerences of immune functions in
infant males and females is essential when developing new
vaccines; (5) that research into immunological mechanisms4 Journal of Tropical Medicine
is of major importance to understanding the interaction
between nutrient supplementation and vaccine eﬃcacy.
In low-income countries with high rates of childhood
mortality, the nonspeciﬁc eﬀects of routine vaccinations are
likely to be of increased importance due to the high disease
burden. The nonspeciﬁc vaccine eﬀectsshould therefore be a
high-priority research area and be considered in the future
planning of immunization programs in these countries to
enhance the beneﬁcial impact of immunizations on child
survival.
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